Thyrocare Technologies Limited Share Price & Analysis

₹576.15−0.43%Updated 4 Sept 2026, 03:30 pm IST

LTP

₹576.15−0.43%

Open

₹577.15

High

₹581.90

Low

₹573.35

₹576.15

52W High

₹662.00

52W Low

₹342.55

Volume

137K

Lot Size

Sector

Healthcare

Market Cap

₹9K Cr

Face Value

₹10

Mid Cap

Price Chart

Candle

Range

Patterns

Fundamentals

P/E

50.70

Sector P/E

54.70

P/B

15.52

EPS

₹10.24

ROE

28.40%

ROCE

35.40%

D/E Ratio

0.09

Div Yield

1.62%

Book Value

₹36.80

Strengths

Excellent return on equity (ROE 28.4%)
Efficient capital deployment (ROCE 35.4%)
Virtually debt-free
Regular dividends — yield 1.6%

Concerns

High premium to book value (P/B 15.5x)

Peer Comparison

Company	CMP	Mkt Cap	P/E	P/B	ROE %	ROCE %	D/E
SUNPHARMA Sun Pharmaceutical Industries Limited	₹1,899	₹4.6L Cr	36.1	5.46	16	20.5	0.07
DIVISLAB Divi's Laboratories Limited	₹9,100	₹2.4L Cr	81.1	14.42	16.5	22	0.01
TORNTPHARM Torrent Pharmaceuticals Limited	₹4,857	₹1.8L Cr	82.8	19.58	27.4	15.2	0.33
APOLLOHOSP Apollo Hospitals Enterprise Limited	₹8,650	₹1.2L Cr	59.1	13.13	21.2	17.4	0.88
CIPLA Cipla Limited	₹1,385	₹1.1L Cr	31.3	3.25	11.6	15.5	0.01
ZYDUSLIFE Zydus Lifesciences Limited	₹1,120	₹1.1L Cr	23	4.16	21.2	21.1	0.38
LAURUSLABS Laurus Labs Limited	₹1,840	₹99K Cr	90.9	18.74	18.3	17.8	0.46

Showing 7 peers in the same sector · Sorted by market cap

Shareholding Pattern

THYROCARE · as of Mar 2026

Promoters71.06%

FII2.41%0.36pp

DII14.97%0.29pp

Public11.57%0.08pp

Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	71.11%	71.11%	71.11%	71.11%	71.06%	71.06%
FII	3.35%	2.90%	2.49%	1.93%	2.77%	2.41%
DII	13.89%	14.88%	14.89%	14.79%	14.68%	14.97%
Public	11.64%	11.11%	11.49%	12.15%	11.49%	11.57%

Corporate Events

Thyrocare Technologies Limited has informed the Exchange about Board Meeting to be held on July 23, 2026 to inter-alia consider and approve the Unaudited Standalone and Consolidated Financial results of the Company for the quarter ended June 30, 2026

Results22 Jul 2026

Dividend - Rs 7 Per Share

Dividend22 Jun 2026

Bonus 2:1

Bonus27 Nov 2025

Interim Dividend - Rs 7 Per Share

Dividend23 Oct 2025

Dividend - Rs 21 Per Share

Dividend24 Jul 2025

Dividend - Rs 18 Per Share

Dividend15 Aug 2024

Latest News

All news

Thyrocare promoter sells 1.58 crore shares

*Thyrocare promoter offloads 1.58 crore shares.* Docon Technologies Private Limited sold **1,57,69,696** equity shares of the company. The stake sale by the promoter entity may signal reduced confidence or fund realignment. Traders should monitor for potential price volatility. 📊 *STOCKS:* $THYROCARE | 🏢 *SECTOR:* Healthcare | #MEDIUMIMPACT #PromoterSelling

NSE Filing13 Aug

Medium Impact

Thyrocare publishes newspaper notice for fund raising

*Thyrocare publishes newspaper notice for fund raising.* The company has issued a newspaper publication related to a fund raising activity, as per a corporate filing on NSE. This is a procedural step and does not disclose size or timing. Such notices are typically routine and informational. 📊 *STOCKS:* $THYROCARE | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #Funding

NSE Filing2d ago

Low Impact

Thyrocare announces 1.75 crore equity shares update

*Thyrocare announces 1.75 crore equity shares update.* The company filed updated equity share data with the NSE, disclosing **1,75,00,000** shares. This reflects routine regulatory disclosure with no immediate financial impact. Investors should monitor for further corporate developments. 📊 *STOCKS:* THYROCARE | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #CorporateFiling

NSE Filing13 Aug

Low Impact

Thyrocare ₹1,000 crore block deal planned

*Thyrocare ₹1,000 crore block deal planned*. A block deal involving **1.5 crore shares** at a floor price of **₹630–631** may result in a **₹1,000 crore** stake sale. The transaction signals significant promoter or investor exit. Such bulk deals can impact short-term price volatility and market sentiment. 📊 *STOCKS:* $THYROCARE | 🏢 *SECTOR:* CapitalMarkets | #MEDIUMIMPACT #BlockDeal

IndiaIPO12 Aug

Medium Impact

Financials

Quarterly Results

Metric	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Revenue	₹224 Cr 14.3%	₹196 Cr 9.7%	₹217 Cr 12.4%	₹193 Cr 3.2%	₹187 Cr 12.7%	₹166 Cr 6.2%	₹177 Cr 12.7%	₹157 Cr
Op. Profit	₹75 Cr 29.3%	₹58 Cr 18.3%	₹71 Cr 22.4%	₹58 Cr 1.8%	₹57 Cr 35.7%	₹42 Cr 12.5%	₹48 Cr 14.3%	₹42 Cr
OPM	34.0% 13.3%	30.0% 9.1%	33.0% 10.0%	30.0% 0.0%	30.0% 20.0%	25.0% 7.4%	27.0% 0.0%	27.0%
Net Profit	₹49 Cr 75.0%	₹28 Cr 41.7%	₹48 Cr 26.3%	₹38 Cr 72.7%	₹22 Cr 15.8%	₹19 Cr 26.9%	₹26 Cr 8.3%	₹24 Cr
EPS (₹)	2.96 62.6%	1.82 39.7%	3.02 23.3%	2.45 80.1%	1.36 13.3%	1.2 28.6%	1.68 10.5%	1.52

Values in ₹ Cr · Source: Screener.in

Annual Profit & Loss

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Revenue	₹829 Cr 20.7%	₹687 Cr 20.1%	₹572 Cr 8.5%	₹527 Cr 10.5%	₹589 Cr 19.0%	₹495 Cr 14.1%	₹434 Cr 7.7%	₹403 Cr 13.2%	₹356 Cr 17.1%	₹304 Cr
Expenses	₹566 Cr 13.7%	₹498 Cr 15.3%	₹432 Cr 7.2%	₹403 Cr 14.2%	₹353 Cr 9.3%	₹323 Cr 23.8%	₹261 Cr 4.8%	₹249 Cr 17.5%	₹212 Cr 12.2%	₹189 Cr
Op. Profit	₹263 Cr 38.4%	₹190 Cr 35.7%	₹140 Cr 13.8%	₹123 Cr 47.9%	₹236 Cr 38.0%	₹171 Cr 1.7%	₹174 Cr 13.0%	₹154 Cr 6.2%	₹145 Cr 26.1%	₹115 Cr
OPM	32.0% 14.3%	28.0% 16.7%	24.0% 4.3%	23.0% 42.5%	40.0% 14.3%	35.0% 12.5%	40.0% 5.3%	38.0% 7.3%	41.0% 7.9%	38.0%
Other Income	₹12 Cr 20.0%	₹15 Cr 66.7%	₹9 Cr 0.0%	₹9 Cr 69.0%	₹29 Cr 141.7%	₹12 Cr 1100.0%	₹1 Cr 90.9%	₹11 Cr 47.6%	₹21 Cr 240.0%	₹-15 Cr
Interest	₹4 Cr 0.0%	₹4 Cr 33.3%	₹6 Cr 20.0%	₹5 Cr 66.7%	₹3 Cr 200.0%	₹1 Cr 50.0%	₹2 Cr 100.0%	₹1 Cr	₹0 Cr	₹0 Cr
Depreciation	₹59 Cr 7.3%	₹55 Cr 17.0%	₹47 Cr 20.5%	₹39 Cr 14.7%	₹34 Cr 13.3%	₹30 Cr 6.3%	₹32 Cr 23.1%	₹26 Cr 30.0%	₹20 Cr 11.1%	₹18 Cr
PBT	₹213 Cr 46.9%	₹145 Cr 51.0%	₹96 Cr 7.9%	₹89 Cr 61.0%	₹228 Cr 50.0%	₹152 Cr 8.6%	₹140 Cr 1.4%	₹138 Cr 4.8%	₹145 Cr 76.8%	₹82 Cr
Tax %	24.0% 36.8%	38.0% 35.7%	28.0% 3.7%	27.0% 17.4%	23.0% 11.5%	26.0% 29.7%	37.0% 2.6%	38.0% 5.6%	36.0% 25.0%	48.0%
Net Profit	₹163 Cr 79.1%	₹91 Cr 31.9%	₹69 Cr 7.8%	₹64 Cr 63.6%	₹176 Cr 55.8%	₹113 Cr 28.4%	₹88 Cr 3.5%	₹85 Cr 8.6%	₹93 Cr 116.3%	₹43 Cr
EPS (₹)	10.24 77.8%	5.76 29.4%	4.45 9.6%	4.06 63.4%	11.1 55.7%	7.13 27.8%	5.58 3.7%	5.38 7.1%	5.79 117.7%	2.66
Div Payout	137.0% 12.3%	122.0% 9.6%	135.0% 8.8%	148.0% 228.9%	45.0% 61.5%	117.0% 290.0%	30.0% 75.8%	124.0% 113.8%	58.0% 53.6%	125.0%

Values in ₹ Cr · Source: Screener.in

Balance Sheet

Item	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Liabilities
Equity Capital	₹159 Cr 200.0%	₹53 Cr 0.0%	₹53 Cr 0.0%	₹53 Cr 0.0%	₹53 Cr 0.0%	₹53 Cr 0.0%	₹53 Cr 0.0%	₹53 Cr 1.9%	₹54 Cr 0.0%	₹54 Cr
Reserves	₹426 Cr 13.8%	₹494 Cr 4.2%	₹474 Cr 1.5%	₹481 Cr 1.5%	₹474 Cr 26.7%	₹374 Cr 19.1%	₹314 Cr 17.8%	₹382 Cr 2.1%	₹390 Cr 10.2%	₹354 Cr
Borrowings	₹51 Cr 104.0%	₹25 Cr 40.5%	₹42 Cr 82.6%	₹23 Cr 9.5%	₹21 Cr 162.5%	₹8 Cr 33.3%	₹12 Cr 500.0%	₹2 Cr	₹0 Cr	₹0 Cr
Other Liabilities	₹111 Cr 8.3%	₹121 Cr 61.3%	₹75 Cr 1.4%	₹74 Cr 23.3%	₹60 Cr 43.4%	₹106 Cr 17.8%	₹90 Cr 143.2%	₹37 Cr 2.8%	₹36 Cr 20.0%	₹30 Cr
Total Liabilities	₹747 Cr 7.8%	₹693 Cr 7.6%	₹644 Cr 1.9%	₹632 Cr 4.1%	₹607 Cr 12.2%	₹541 Cr 15.4%	₹469 Cr 1.3%	₹475 Cr 0.8%	₹479 Cr 9.4%	₹438 Cr
Assets
Fixed Assets	₹317 Cr 6.7%	₹297 Cr 2.9%	₹306 Cr 4.1%	₹294 Cr 3.2%	₹285 Cr 12.6%	₹253 Cr 5.9%	₹269 Cr 8.5%	₹294 Cr 1.7%	₹299 Cr 15.4%	₹259 Cr
CWIP	₹3 Cr 78.6%	₹14 Cr 366.7%	₹3 Cr 50.0%	₹2 Cr 33.3%	₹3 Cr 62.5%	₹8 Cr 60.0%	₹5 Cr 400.0%	₹1 Cr	₹0 Cr 100.0%	₹17 Cr
Investments	₹177 Cr 9.3%	₹162 Cr 0.0%	₹162 Cr 12.5%	₹144 Cr 1.4%	₹146 Cr 15.9%	₹126 Cr 40.0%	₹90 Cr 5.3%	₹95 Cr 20.8%	₹120 Cr 15.4%	₹104 Cr
Other Assets	₹250 Cr 13.6%	₹220 Cr 27.2%	₹173 Cr 9.9%	₹192 Cr 11.0%	₹173 Cr 12.3%	₹154 Cr 46.7%	₹105 Cr 25.0%	₹84 Cr 40.0%	₹60 Cr 3.4%	₹58 Cr
Total Assets	₹747 Cr 7.8%	₹693 Cr 7.6%	₹644 Cr 1.9%	₹632 Cr 4.1%	₹607 Cr 12.2%	₹541 Cr 15.4%	₹469 Cr 1.3%	₹475 Cr 0.8%	₹479 Cr 9.4%	₹438 Cr

Values in ₹ Cr · Source: Screener.in

Cash Flow Statement

Item	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Operating CF	₹213 Cr 11.5%	₹191 Cr 13.7%	₹168 Cr 30.2%	₹129 Cr 14.2%	₹113 Cr 1.7%	₹115 Cr 31.5%	₹168 Cr 68.0%	₹100 Cr 6.5%	₹107 Cr 18.9%	₹90 Cr
Investing CF	₹-23 Cr 56.6%	₹-53 Cr 41.8%	₹-91 Cr 133.3%	₹-39 Cr 62.5%	₹-24 Cr 51.0%	₹-49 Cr 5000.0%	₹1 Cr 108.3%	₹-12 Cr 72.1%	₹-43 Cr 2.4%	₹-42 Cr
Financing CF	₹-170 Cr 30.8%	₹-130 Cr 52.9%	₹-85 Cr 1.2%	₹-86 Cr 3.4%	₹-89 Cr 43.5%	₹-62 Cr 62.4%	₹-165 Cr 75.5%	₹-94 Cr 46.9%	₹-64 Cr 30.6%	₹-49 Cr
Net Cash Flow	₹21 Cr 162.5%	₹8 Cr 200.0%	₹-8 Cr 300.0%	₹4 Cr	₹0 Cr 100.0%	₹4 Cr 0.0%	₹4 Cr 180.0%	₹-5 Cr	₹0 Cr	₹0 Cr
Free Cash Flow	₹198 Cr 35.6%	₹146 Cr 36.4%	₹107 Cr 21.6%	₹88 Cr 11.1%	₹99 Cr 6.5%	₹93 Cr 41.1%	₹158 Cr 159.0%	₹61 Cr 3.2%	₹63 Cr 18.9%	₹53 Cr

Values in ₹ Cr · Source: Screener.in

Key Ratios History

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Debtor Days	33d 15.4%	39d 39.3%	28d 52.5%	59d 1.7%	58d 75.8%	33d 135.7%	14d 27.3%	11d 10.0%	10d 25.0%	8d
Inventory Days	81d 9.0%	89d 14.4%	104d 67.7%	62d 17.0%	53d 1.9%	52d 18.8%	64d 6.7%	60d 9.1%	66d 1.5%	65d
Days Payable	109d 25.3%	146d 65.9%	88d 63.0%	54d 50.0%	36d 35.7%	56d 17.6%	68d 172.0%	25d 0.0%	25d 316.7%	6d
Cash Conv. Cycle	4d 122.2%	-18d 140.9%	44d 34.3%	67d 10.7%	75d 158.6%	29d 190.0%	10d 78.3%	46d 8.0%	50d 25.4%	67d
Working Capital Days	19d 46.2%	13d 85.7%	7d 77.4%	31d 24.4%	41d 115.8%	19d 337.5%	-8d 128.6%	28d 180.0%	10d 47.4%	19d
ROCE	35.0% 40.0%	25.0% 38.9%	18.0% 5.9%	17.0% 59.5%	42.0% 16.7%	36.0% 2.9%	35.0% 16.7%	30.0% 9.1%	33.0% 17.9%	28.0%

Source: Screener.in · Lower days = better efficiency

Same Sector

ALKEMAlkem Laboratories LimitedNeutral APOLLOHOSPApollo Hospitals Enterprise LimitedNeutral AUROPHARMAAurobindo Pharma LimitedNeutral BIOCONBiocon LimitedNeutral CIPLACipla LimitedNeutral

Frequently Asked Questions

What is Thyrocare Technologies Limited share price today?

Thyrocare Technologies Limited (THYROCARE) is currently trading at ₹576.15 on NSE, down 0.43% as of the last market session. Prices update daily after market close on MarketNetra.

Is Thyrocare Technologies Limited available in F&O (Futures & Options)?

Yes, Thyrocare Technologies Limited (THYROCARE) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.

What is Thyrocare Technologies Limited 52-week high and low?

Thyrocare Technologies Limited's 52-week high is ₹662 and the 52-week low is ₹342.55. The current price of ₹576.15 is 13.0% below the 52W high.

What is Thyrocare Technologies Limited P/E ratio?

Thyrocare Technologies Limited's current P/E ratio is 50.7. This indicates the market is paying ₹50.7 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.

How to trade Thyrocare Technologies Limited options?

Thyrocare Technologies Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade THYROCARE options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.

Thyrocare Technologies Limited Share Price & Analysis

Price Chart

Fundamentals

Peer Comparison

Shareholding Pattern

Corporate Events

Latest News

Financials

Quarterly Results

Annual Profit & Loss

Balance Sheet

Cash Flow Statement

Key Ratios History

Related Analysis

Same Sector

Frequently Asked Questions